The announcement states:
The securities of Chimeric Therapeutics Limited (‘CHM’) will be placed in trading halt at the request of CHM,
pending it releasing an announcement regarding the outcome of the institutional component of the
accelerated entitlement offer.
So I guess us mere retail mortals will receive some communication from CHM at some stage about the offer.
